Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
SGK1-mediated deficits in microglial phagocytosis drive pathological progression in amyotrophic lateral sclerosis.
The role of SUMOylation in regulating proteins that drive neuronal disease progression.
Effectiveness of the adapted Unified Protocol (UP-MSo) in relapsing-remitting multiple sclerosis with overweight/obesity: A pre-registered randomized controlled trial on emotion regulation, eating behavior, and neurological outcomes.
A Practical Guide to Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Systematic review- hormone replacement therapy in postmenopausal women with medical co-morbidities.
[From Bite to Loss of Vision-Ocular Complications of West Nile Virus].
Longitudinal assessment of sNfL and sGFAP in severe NMOSD treated with allogeneic stem cell transplantation.
Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum.
Language Model Embedding Classifiers Enable Identification of Multiple Sclerosis-Associated BCRs and Repertoires.
Therapeutic Use of Medical Cannabis Beyond Pain Management in Physical Medicine and Rehabilitation.
Testing the construct validity of real-world digital mobility outcomes in multiple sclerosis.
Perspectives of participating neurologists and study nurses - Mixed-methods process evaluation of a web-based program for relapse management in multiple sclerosis (POWER@M2).
Data-Driven Fatigue Trajectories in Multiple Sclerosis and Their Predictors.
Generalizable spinal cord multiple sclerosis lesion segmentation across MRI contrasts, protocols, and centers.
Regulatory B cells in the central nervous system: From immune regulation to neuroprotection.
The meningeal lymphatic vessel-peripheral immune axis: a novel therapeutic target in neurodegenerative diseases.
Cellular Senescence in Neurodegeneration: From Cell Types to Therapeutic Opportunities.
Post-ischemic modification of neurogenesis and oligodendrogenesis in rodent models.
Astrocyte Functional Heterogeneity in Multiple Sclerosis.
Task-Oriented Training for Rehabilitation in Multiple Sclerosis in a Non-Hospital Setting: A Protocol for a Randomized Controlled Trial.
Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis - Authors' reply.
GV1001: repurposing a telomerase-derived peptide for neurological therapeutics.
Synthesis strategies of gold nanoclusters and their application in anti-inflammatory therapy.
Correction to "Severe Hyponatremia in the Emergency Department. Incidence of Cerebral Edema and Risk of Osmotic Demyelination Syndrome".
Multiple Sclerosis Drug Fingolimod Exhibits Antibacterial Activity through Bacterial Membrane Permeabilization.
Pages
« first
‹ previous
…
1000
1001
1002
1003
1004
1005
1006
1007
1008
…
next ›
last »